The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame

Sue Ann Costa Clemens, Gustavo Mendes Lima Santos, Isabela Gonzalez, Ralf Clemens

Open source

DOI
10.26633/rpsp.2023.99
Published
2023-07-03
Container
Revista Panamericana de Salud Pública
Publisher
Pan American Health Organization
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26633/rpsp.2023.99,
  title = {The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame},
  author = {Sue Ann Costa Clemens and Gustavo Mendes Lima Santos and Isabela Gonzalez and Ralf Clemens},
  year = {2023},
  journal = {Revista Panamericana de Salud Pública},
  doi = {10.26633/rpsp.2023.99},
  url = {https://doi.org/10.26633/rpsp.2023.99}
}

RIS

TY  - JOUR
TI  - The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame
AU  - Sue Ann Costa Clemens
AU  - Gustavo Mendes Lima Santos
AU  - Isabela Gonzalez
AU  - Ralf Clemens
PY  - 2023
JO  - Revista Panamericana de Salud Pública
DO  - 10.26633/rpsp.2023.99
UR  - https://doi.org/10.26633/rpsp.2023.99
ER  - 

APA

Clemens, S. A. C., Santos, G. M. L., Gonzalez, I., & Clemens, R. (2023). The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame. Revista Panamericana de Salud Pública. https://doi.org/10.26633/rpsp.2023.99

Source records